Clinical Trial Update: Therapeutic Study of ONO-4819CD for Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 study of ONO-4819CD for Ulcerative Colitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ONO-4819CD

Snippet

Sponsor: Kyoto University, Graduate School of Medicine | Conditions: Ulcerative Colitis | Phase 2 | Status: TERMINATED